1
|
Anogeianaki A, Angelucci D, Cianchetti E,
et al: Atherosclerosis: a classic inflammatory disease. Int J
Immunopathol Pharmacol. 24:817–825. 2011.PubMed/NCBI
|
2
|
Mahmoudi M, Curzen N and Gallagher PJ:
Atherogenesis: the role of inflammation and infection.
Histopathology. 50:535–546. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mantovani A: Cancer: Inflaming metastasis.
Nature. 457:36–37. 2009. View
Article : Google Scholar
|
4
|
Duffield JS: The inflammatory macrophage:
a story of Jekyll and Hyde. Clin Sci (Lond). 104:27–38. 2003.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Jakobsson PJ: Pain: how macrophages
mediate inflammatory pain via ATP signaling. Nat Rev Rheumatol.
6:679–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fujiwara N and Kobayashi K: Macrophages in
inflammation. Curr Drug Targets Inflamm Allergy. 4:281–286. 2005.
View Article : Google Scholar
|
7
|
Yu Zhijun, Zhao Luhang and Ke Haiping:
potential role of nuclear factor-kappaB in the induction of nitric
oxide and tumor necrosis factor-alpha by oligochitosan in
macrophages. International immunopharmacology. 4:193–200. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Nishimura K, Nishmura K, Nishi N, et al:
Immunological activity of chitin and its derivatives. Vaccine.
2:93–99. 1984. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tokoro A, Kobayashi M, Tatewaki N, et al:
Protective effect of N-acetyl-chitohexaose on Listeria
monocytogenes infection in mice. Microbiol Immunol. 33:357–367.
1989. View Article : Google Scholar
|
10
|
Suzuki K, Mikami T, Okawa Y, et al:
Antitumor effect of hexa-N-acetylchitohexaose and chitohexaose.
Carbohydr Res. 151:403–408. 1986. View Article : Google Scholar : PubMed/NCBI
|
11
|
Jeong HJ, Koo HN, Oh EY, et al: Nitric
oxide production by high molecular weight water-soluble chitosan
via nuclear factor-kappaB activation. Int J Immunopharmacol.
22:923–933. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Arthur Felse P and Panda T: Studies on
applications of chitin and its derivatives. Bioprocess Biosyst Eng.
20:505–512. 1999.
|
13
|
Synowiecki J and Al-Khateeb NA:
Production, properties, and some new applications of chitin and its
derivatives. Crit Rev Food Sci Nutr. 43:145–171. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Lawrence T, Willoughby DA and Gilroy DW:
Anti-inflammatory lipid mediators and insights into the resolution
of inflammation. Nat Rev Immuno. 2:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
DeGeorge GL, Heck DE and Laskin JD:
Arginine metabolism in keratinocytes and macrophages during nitric
oxide biosynthesis: multiple modes of action of nitric oxide
synthase inhibitors. Biochem Pharmacol. 54:103–112. 1997.
View Article : Google Scholar
|
17
|
Rubbo H, Tarpey M and Freeman BA: Nitric
oxide and reactive oxygen species in vascular injury. Biochem Soc
Symp. 61:33–45. 1995.PubMed/NCBI
|
18
|
He Xiaojuan, Shu Jun, Xu Li, et al:
inhibitoy effect of Astragalus polysaccharides on
lipopolysaccharide-induced TNF-α and IL-1β production in THP-1
cells. Molecules. 17:3155–3164. 2012.
|